课题基金 / 基金详情

Closing the Comorbidity Gap for People Living with HIV : a Randomized Controlled Trial of Fostemsavir to Reduce Inflammaging

Closing the Comorbidity Gap for People Living with HIV : a Randomized Controlled Trial of Fostemsavir to Reduce Inflammaging
缩小艾滋病毒感染者的合并症差距:Fostemsavir 减少炎症的随机对照试验
批准号:
485532
负责人:
Durand Madeleine
金额:
$1.46万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-03-01 至 2024-03-01

项目摘要

项目成果

Durand Madeleine的其他基金

相似基金

相关文献

中文摘要
翻译
艾滋病毒携带者现在的寿命越来越长,目前的数据显示,一些人可能希望拥有正常的预期寿命。然而,与衰老相关的疾病,如心血管疾病、骨质疏松症或神经认知疾病,可能会更早发生在
英文摘要
People living with HIV now live increasingly longer, and current data show that some might hope to have normal life expectancy. However, aging-related diseases such as cardiovascular disease, osteoporosis, or neuro-cognitive disease may happen sooner for
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovering pathways to successful aging in HIV infection
2nd Canadian HIV and Aging symposium Engaging actors for better aging with HIV
Discovering immune pathways to successful aging in HIV infection
海外基金